The Research Caught Up This Year

Research in Mind-Body Medicine for Cancer Finally Offers Hope

Most of what happens in cancer treatment happens to us rather than through us. That, however, doesn't mean we’re helpless or without agency. It seems that the space around treatment – the hours between appointments and the weeks between scans – is not empty. And this year, research on what fills that space became considerably more interesting.

A program delivered from home, and a signal worth noticing

At Memorial Sloan Kettering, a team ran a trial called IMPROVE. Two hundred people with solid tumors, all of them on systemic therapy or radiation, all of them living with moderate to severe fatigue, were randomly assigned either to twelve weeks of live virtual classes combining mind-body practice and structured exercise, or to usual care with on-demand meditation resources added. The program had already been shown to reduce fatigue, anxiety, depression, and overall symptom burden. It had also reduced emergency room visits, hospitalizations, and interruptions to treatment.

This summer the investigators went back and asked a further question. Among 127 of those participants, followed for a median of just over two years, the group that had done the program was more likely to be alive at twenty-four months: 69.1% compared with 52.6%.

Now hold that number carefully, because the trial was never designed to measure survival. The finding was exploratory; it did not hold up under every statistical test they applied, and factors they could not measure, such as how motivated a person was to begin with, may have shaped the result. This is a signal, not a conclusion.

What matters is the mechanism the investigators proposed. Less fatigue, less distress, and better tolerance of treatment. People who feel steadier (mentally and emotionally) may be more able to complete the treatment their oncologist prescribed. That is not a mystery. That is arithmetic.

Three hypnosis sessions, and a year of relief

A second trial, this one from the Center for Behavioral Oncology at Mount Sinai, worked with 154 women who had finished breast cancer treatment and were taking aromatase inhibitors, a class of drugs that lowers estrogen to reduce the risk of recurrence and that commonly leaves joints aching and stiff. Half received three sessions of clinical hypnosis. Half received the same amount of time with a warm, attentive professional who did not use hypnosis.

Pain severity and interference were lower in the hypnosis group at every follow-up point for a full year. There were no adverse events. The women were taught self-hypnosis in the first session and given recordings to practice with at home, which means the benefit did not depend on returning to a clinician indefinitely.

I have spent more than twenty years in this work, and this is the study I have been waiting for. Not because it proves something I already believed, but because of its shape. Three sessions. Skills handed over rather than held onto. A year of measurable difference, funded and published by the National Center for Complementary and Integrative Health. The intervention ended, and the effect did not.

What the sham group tells us

The third finding is the one people find most confusing, and it is my favorite.

Researchers at the University of Michigan taught 171 ovarian cancer survivors to perform self-acupressure using a mobile app. After six weeks, 58% of the women doing true acupressure had returned to a clinically normal level of fatigue. In the usual care group, 18% had. So far, unsurprising.

Here is the part that matters: in the sham group, the women pressing points chosen to do nothing, the figure was 51%.

Read the wrong way, and that finding dismisses the whole thing. Read correctly, it points somewhere far more useful. If the specific points mattered less than the daily practice of sitting down, placing your hands on your own body, and attending to it for a few minutes, then the active ingredient may be the practice itself. The regularity. The attention. Not all of the benefit, but a great deal of it, appears to live in the doing.

We are trained to look for the special technique, the correct protocol, the thing that works because of some particular mechanism. Sometimes the mechanism is simply that you showed up for yourself, daily, for six weeks.

Worth noting honestly: more people dropped out of the acupressure groups than out of usual care. This does not suit everyone, and that is fine.

The unglamorous finding

In a study of 153 people with melanoma or sarcoma receiving immune checkpoint blockade, a treatment that releases the brakes on the immune system so it can recognize tumor cells, outcomes were tracked alongside how much dietary fiber people were eating. A separate review this year reached a similar conclusion: higher fiber intake was associated with better response to immunotherapy and with favorable shifts in gut bacteria.

Vegetables, beans, whole grains. Nothing to purchase, nothing to believe in.

I include it because it makes the point more plainly than anything else on this list. The question is never whether to choose your treatment or your habits. The question is what you can do, in the ordinary hours, that supports the treatment you are already receiving. Work alongside your medical team. Always alongside.

Where this is heading

University Hospitals in Cleveland published sixteen months of results from an integrative oncology clinic covered by insurance, reporting meaningful improvements in pain, stress, anxiety, depression, nausea and fatigue. Not a boutique program. A covered service inside a health system.

And this month the American Association for Cancer Research released its annual progress report. There are now more than 18.6 million people in the United States living with a history of cancer, and the death rate has fallen 35% since 1991. That is a very large number of people whose treatment succeeded and whose lives continue, with all the fatigue and fear and unfinished business that come after.

One thing this research does not say

There is a growing literature on chronic stress and tumor biology, showing how sustained activation of the stress response can alter the environment around a tumor and dampen immune surveillance. Psychoneuroimmunology, the study of how thoughts and emotions interact with the nervous and immune systems, has been mapping these pathways for decades.

Still, here is what that work does not establish, and what I will not let be used against you. Your stress did not give you cancer. A modeling study published this year found that stress alone had little predictive power for whether someone developed the disease, and no clear causal link has been demonstrated. You did not do this to yourself.

What the science does suggest is narrower and more useful: your system has been under pressure, and conditions that support the body's recovery can be influenced. Not the cause of the illness, but the conditions for healing.

That distinction is the difference between guilt and agency. Guilt looks backward and takes something from you. Agency looks at tomorrow morning and asks what is available.

Something is. It always is.

Sources:

• Daly B, Bryl K, Santos Teles M, et al. Survival results from the IMPROVE trial. JCO Oncology Advances, 2026. Reported in The ASCO Post, August 25, 2026.

• Montgomery GH, Schnur JB, Tiersten A, et al. A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors. Psychology of Consciousness, 2025.

• Zick SM, Chen D, Harris RE, et al. Self-Acupressure for Fatigue in Patients Surviving Ovarian Cancer: A Randomized Clinical Trial. JAMA Network Open, February 2026.

• Fields BC, Daniel CR, Wargo JA, et al. High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy. Cancer, 2026.

• Sousa MF de A, et al. Impact of Dietary Fiber Intake on the Immunological Response to Immunotherapy in Cancer Patients: A Scoping Review. Cancer Medicine, 2026.

• Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program. JCO Oncology Practice, 2026.

• American Association for Cancer Research. AACR Cancer Progress Report 2026.

• Chronic Stress, Immune Suppression, and Cancer Occurrence: Unveiling the Connection Using Survey Data and Predictive Models. Medical Sciences, May 2026.

Avinoam Lerner is a cancer and trauma recovery specialist with 25 years of practice in Boston, MA. He is the author of The New Cancer Paradigm and Mindful Remission, and his work is grounded in psychoneuroimmunology and the science of mind-body healing.AvinoamLerner.com